Jerzy Szewczyk
Works at
Ceo and cso
Sources: reporter.nih.gov
Grants and prizes
National Heart, Lung, and Blood Institute
R43, Clinical development of a colon-targeted butyrate tablet to evaluate effects on cholesterol and trimethyl amine oxide in subjects at risk for cardiovascular disease, R43HL174321, 2024–2026, 5 Jul 2024
Sources: reporter.nih.gov